What is it about?
In this research paper, we evaluated the effect of Curcuma longa and Boswellia serrata extracts in an in vitro model of IBD using intestinal cells (Caco2) and immune cells (PBMC and mast cells).
Featured Image
Why is it important?
This work strengthen the current knowledge on Curcuma longa and Boswellia serrata effectiveness in the management of IBD, by underline the anti-inflammatory mechanism of action of Curcuma longa and the antioxidant mechanism of action of Boswellia serrata, both preventing intestinal barrier dysfunction and protecting from leucocyte infiltration.
Perspectives
This work should represent the starting point for novel research, hopefully at clinical level, to further spread the use of herbal medicine in support to conventional IBD therapies.
Mr Paolo Governa
Universita degli Studi di Siena
Read the Original
This page is a summary of: Effects of Boswellia Serrata Roxb. and Curcuma longa L. in an In Vitro Intestinal Inflammation Model Using Immune Cells and Caco-2, Pharmaceuticals, November 2018, MDPI AG,
DOI: 10.3390/ph11040126.
You can read the full text:
Contributors
The following have contributed to this page
